Trials / Recruiting
RecruitingNCT06467968
Heart Analysis in GATED-PET in Patients Having a Gallium-68-DOTATOC PET/CT Exam for Oncology Indication
GATED-PET Heart Analysis in Patients Having a Gallium-68--DOTATOC PET/CT Exam for Oncology Indication
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 99 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subtype 2 (SSTR2) receptors and these somatostatin receptors are also overexpressed on inflammation cells when activated. The hypothesis is that the GATED mode on a Gallium-68-DOTATOC cardiac recording would be able to highlight abnormalities that could be correlated with the age of the patients and their cardiovascular risk factors.
Detailed description
People with the selection criteria for the study, coming to the nuclear medicine department in order to benefit from a Gallium-68-DOTATOC PET/CT exam as part of a diagnostic or pre-therapeutic assessment of a neuroendocrine tumor will be offer to participate in the study After sign consent, patients were install in a room to have blood drawn for Troponin Ic, BNP and CRP and after Gallium-68-DOTATOC infusion Gallium-68-DOTATOC PET/CT will be recorded and immediately the cardiac record in Gated mode
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cardiac ECG-gated PET imaging will added | Blood sample will be used to measure troponin, BNP and CRP . After 68Ga-DOTATOC PET/CT whole body recording, a cardiac ECG-gated PET imaging will added |
Timeline
- Start date
- 2023-02-02
- Primary completion
- 2024-11-24
- Completion
- 2025-08-26
- First posted
- 2024-06-21
- Last updated
- 2024-06-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06467968. Inclusion in this directory is not an endorsement.